Paris, France

Eric Bruckert

This inventor holds 1 USPTO granted patent. Top assignee: Fournier Laboratories Ireland Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Bruckert. Retrieved from https://idiyas.com/inventor/eric-bruckert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Eric Bruckert

Introduction

Eric Bruckert is a notable inventor based in Paris, France. He has made significant contributions to the pharmaceutical industry, particularly in the treatment of sleep apnea. His innovative approach has led to the development of a unique application of fibrates, which has the potential to improve the lives of many individuals suffering from this condition.

Latest Patents

Eric Bruckert holds a patent for the use of fibrates, specifically fenofibrate, in the form of a solid oral composition. This invention is aimed at manufacturing a drug for the treatment of sleep apnea, particularly obstructive sleep apnea syndrome. His patent represents a significant advancement in the pharmaceutical field, addressing a critical health issue.

Career Highlights

Bruckert is associated with Fournier Laboratories Ireland Limited, where he has been instrumental in advancing research and development in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the industry.

Conclusion

Eric Bruckert's innovative work in the field of pharmaceuticals, particularly with his patent on fibrates for sleep apnea treatment, showcases his dedication to improving healthcare solutions. His contributions are a testament to the impact that inventors can have on society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…